Acetylcholinesterase (AChE)
Acetylcholinesterase (AChE; EC 3.1.1.7) is a serine hydrolase enzyme that catalyzes the rapid breakdown of the neurotransmitter acetylcholine into choline and acetate, terminating cholinergic signaling at synapses and neuromuscular junctions.
Acetylcholinesterase (AChE; EC 3.1.1.7) is a serine hydrolase enzyme that catalyzes the rapid breakdown of the neurotransmitter acetylcholine into choline and acetate, terminating cholinergic signaling at synapses and neuromuscular junctions. Its catalytic machinery sits at the base of a deep, narrow active-site gorge lined by aromatic residues, with a catalytic triad at one end and a peripheral anionic site at the gorge mouth — an architecture that gives the enzyme both extraordinary turnover speed and two spatially distinct pockets that inhibitors can be designed to occupy. The protein is expressed in cholinergic neurons, at motor endplates, and on erythrocyte membranes, where it also carries the Yt blood group antigen; red blood cell AChE activity is used clinically as a marker of cholinesterase status. Beyond hydrolysis, AChE has been implicated in non-catalytic roles including cell adhesion, neurite outgrowth, and responses to oxidative stress and apoptotic signaling.
Pharmacologically, AChE is a central drug target. Inhibiting it raises synaptic acetylcholine levels, the mechanism behind cholinergic therapy for Alzheimer's disease with agents such as donepezil, and much current medicinal chemistry — coumarin carboxamides, flavonoids and biflavonoids, and other plant-derived scaffolds such as chrysin, apigenin, naringenin, hesperidin, and rosmarinic acid — is screened for AChE inhibition alongside the closely related butyrylcholinesterase, which hydrolyzes a broader range of esters and becomes proportionally more important as AChE activity declines in the aging brain. Because such compounds must reach the central nervous system, blood–brain barrier permeability is a routine consideration in their evaluation, often alongside docking, molecular dynamics, and QSAR modeling. AChE inhibition is frequently studied together with other Alzheimer's-relevant targets including beta-secretase 1, glycogen synthase kinase 3β, and amyloid beta, and with markers of oxidative stress and neuroinflammation such as superoxide dismutase, catalase, glutathione, reactive oxygen species, Tnf-α, IL-1β, and COX-2 — a combination that links AChE to work on diabetes-associated neurodegeneration, where insulin resistance and hyperglycemia accompany cholinergic and hippocampal damage and where dual-acting agents such as SGLT2 inhibitors have been examined. Conversely, irreversible inhibition of AChE by organophosphate pesticides and nerve agents causes acetylcholine accumulation and the cholinergic toxidrome, and the enzyme's sensitivity to these compounds is itself exploited in biosensors that detect organophosphate residues.
Where the papers sit
43 papers from the last 6 months study Acetylcholinesterase (AChE) directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 9 human data · 34 preclinical
Themes 5 themes · 1 new direction
-
Multitarget Neuroprotective Agents
Cholinesterase inhibitor discovery is being combined with antioxidant, anti-inflammatory, carbonic anhydrase, COX, or MAO-B activity to address neurodegeneration more broadly. Heterocyclic, sulfonamide, hydrazone, coumarin, and donepezil-like compounds are assessed through enzyme kinetics, structural studies, and computational modeling. Memory enhancement and protection from oxidative injury provide early in vivo or functional support. The cluster also retains niche applications such as nerve-agent reactivation, so clinical direction remains unsettled.
19 papers · 44.2%
-
Dual Cholinesterase Inhibitors
New Alzheimer disease candidates are moving beyond single-target AChE inhibition toward dual AChE and BCHE activity. Donepezil-inspired hybrids, carbamates, oxadiazoles, coumarins, and flavonoid-based scaffolds are repeatedly optimized for potency and ADMET properties. Molecular docking and dynamics support structure-guided refinement, while neuroprotective effects are emerging as a key endpoint. Translation remains open because most evidence is biochemical or computational.
10 papers · 23.3%
-
Amyloid–Cholinesterase Alzheimer Therapy
Alzheimer disease strategies are increasingly pairing AChE inhibition with Amyloid-β aggregation blockade, oxidative-stress control, or inflammatory pathway suppression. Phytochemical carbamate hybrids and dual GSK-3β/AChE inhibitors seek broader disease modification than symptomatic cholinesterase inhibition alone. Targeted liposomes and nanozyme or fluorescence platforms add delivery and activity-monitoring capabilities. The recurring challenge is proving that these multitarget designs improve neurodegeneration or cognition beyond enzyme-level potency.
7 papers · 16.3%
-
Natural Product AChE Discovery
Botanical extracts are being fractionated and profiled to identify natural AChE-binding constituents with neuroprotective or insecticidal potential. LC-MS, NMR, affinity-guided separation, and activity-oriented purification recur across the work. Ginsenosides, flavonoids, furanocoumarins, and fungal or plant metabolites are the principal discovery space. The field is moving from crude-extract activity toward chemically defined compounds, but selectivity and in vivo validation remain limited.
4 papers · 9.3%
-
Chemical Evaluation of AChE Modulators
Plant extracts and synthetic scaffolds are being evaluated together through chromatographic profiling, enzyme assays, docking, and cell-based toxicity testing. Amentoflavone-type biflavonoids and chiral urea or thiourea compounds recur as candidate bioactive chemotypes. The work emphasizes linking chemical composition and predicted binding to biological activity. Evidence remains exploratory, with no clear lead compound or therapeutic direction yet.
3 papers · 7%
AChE inhibition is presented as a central antitussive mechanism rather than solely an Alzheimer’s-related therapeutic or assay target
The rabbit cough-reflex study of donepezil 42537636Jul assumed that inhibiting AChE could test whether increased synaptic acetylcholine modulates airway-defense circuits, and found suppressive effects on the cough reflex. This assigns AChE a role outside the set’s usual Alzheimer’s disease, neuroprotection, inhibitor-screening, and biosensing contexts: it becomes a pharmacological lever for centrally regulating cough, opening a potential antitussive direction.
Papers
The 43 papers from the last 6 months that study Acetylcholinesterase (AChE) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Multitarget Neuroprotective Agents (19)
- Molecular Insights on the Reduction-Dependent Electronic Modulation of Graphene Oxide Surface Toward Reactivity and Acetylcholinesterase Inhibition of Alzheimer's Drugs. Chemphyschem : a European journal of chemical physics and physical chemistry · 5 Nov 2026 PMID 42984381
- Towards Greener Pastures in Alzheimer's Therapy: Synthesis and XRD/HSA/DFT Mechanistic Investigation of Novel Trifluoromethylated Compounds. Archiv der Pharmazie · 29 Oct 2026 PMID 42956264
- Discovery of novel pyridine-2-tetrazole derivatives as in vivo memory enhancement agents. Bioorganic chemistry · 28 Oct 2026 PMID 42950793
- Structural optimization of donepezil-like hybrids toward an improved multi-target and ADME-related profile. Bioorganic chemistry · 2 Oct 2026 PMID 42826663
- Novel pyrimidine-based N-Acylhydrazones as dual AChE inhibitors and antioxidants targeting Alzheimer's disease. Bioorganic chemistry · 28 Sept 2026 PMID 42804920
- Design, synthesis and multitarget evaluation of cyclopropyl-appended thiohydantoin derivatives as dual cholinesterase and COX inhibitors with antioxidant activity: a combined experimental and computational study. Journal of computer-aided molecular design · 11 Sept 2026 PMID 42726329
- Neuroprotective potential of synthesized coumarin-based glycinate and heterocyclic amide derivatives: an acetylcholinesterase inhibition study. Scientific reports · 25 Aug 2026 PMID 42642505
- Sulfonamide-Based 2-Amino-1,3,4-Oxadiazole Derivatives as Dual Cholinesterase and Carbonic Anhydrase Inhibitors: Design, Synthesis, Kinetic Characterization, Molecular Modeling, and ADMET Evaluation. Drug development research · 25 Aug 2026 PMID 42638586
- Design, Synthesis, and Biological Evaluation of Benzimidazol-2-One Hybrids as Potential Anti-Alzheimer's Disease Agents. Drug development research · 20 Aug 2026 PMID 42623026
- Dual enzymatic inhibition and toxicity profiling of polymethoxylated flavones isolated from Knema malayana. Journal of computer-aided molecular design · 7 Aug 2026 PMID 42563004
- Central cholinergic modulation of the cough reflex: suppressive effects of donepezil in rabbits. American journal of physiology. Lung cellular and molecular physiology · 31 Jul 2026 PMID 42537636
- Phenylsulfonylethyl-Substituted Benzimidazolium Salts: Synthesis, Characterization, Crystal Structure, Molecular Docking, and Inhibitory Properties Against Various Enzymes. Journal of biochemical and molecular toxicology · 26 Jul 2026 PMID 42502223
- RANQSAR: a standalone open-source application for reproducible machine learning-based QSAR analysis. Journal of computer-aided molecular design · 2 Jul 2026 PMID 42390765
- From Poisoning to Signal Transduction: d-Band Modulated Au@RuPt Nanozyme for Oxygen Reduction Reaction Inhibition-Based Detection of Organophosphates. Analytical chemistry · 1 Jul 2026 PMID 42384538
- Ferric chloride mediated synthesis, photophysical and in vitro anti-Alzheimer's properties of 1H-pyrrolo[2,3-b]pyridin-3-ylmethylphenyl-2-(9H-fluoren-9-ylidene)-1-phenylethan-1-imines. Organic & biomolecular chemistry · 19 Jun 2026 PMID 42318800
- Design, synthesis and evaluation of an uncharged broad spectrum quinoline-oxime hybrid for the reactivation of nerve agent-inhibited human acetylcholinesterase. European journal of medicinal chemistry · 4 Jun 2026 PMID 42241775
- Evaluation of the Phytochemical Composition, Antioxidant Activity, and Enzyme Inhibitory Potential of Salvia heldreichiana Within the Framework of Molecular Docking and CAVER Tunnel Analysis. ChemistryOpen · 1 Jun 2026 PMID 42220228
- Identification of a nanomolar, selective MAO-B inhibitor from piperidine-based chalcones with anti-Parkinson potential. Bioorganic chemistry · 26 May 2026 PMID 42190536
- Bismuth hybrid halide with dual inhibition against α-amylase and acetylcholinesterase probed by structural, vibrational, and theoretical analysis. Journal of materials chemistry. B · 22 May 2026 PMID 42171151
Dual Cholinesterase Inhibitors (10)
- New hybrid molecules with 2,3,4,9-tetrahydro-1H-carbazol-1,3,4-oxadiazole-N-phenylacetamide framework as potent cholinesterase inhibitors. Future medicinal chemistry · 22 Oct 2026 PMID 42904391
- Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors. Drug development research · 14 Sept 2026 PMID 42734044
- Design, synthesis, biological evaluation, and in silico analysis of novel coumarin carboxamides as acetylcholinesterase and butyrylcholinesterase inhibitors and anticancer agents. Journal of computer-aided molecular design · 21 Jul 2026 PMID 42481895
- Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells. Bioorganic chemistry · 16 Jul 2026 PMID 42462519
- Eugenol-derived carbamates as sub-nanomolar dual cholinesterase inhibitors with neuroprotective activity against Alzheimer's disease: Structure-activity relationships and molecular dynamics insights. Bioorganic chemistry · 13 Jul 2026 PMID 42442298
- Novel 2-indolinone benzylpiperidine- thiosemicarbazone hybrids as cholinesterase inhibitors: Design, synthesis and biological evaluation. Bioorganic chemistry · 29 Jun 2026 PMID 42372459
- The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer's disease induced by intracerebroventricular injection of streptozotocin. Brain structure & function · 14 Jun 2026 PMID 42289507
- β-Maltose-conjugated acetophenone thiosemicarbazones as multitarget inhibitors of diabetes- and Alzheimer's disease-related enzymes: Design, synthesis, and mechanistic evaluation. Bioorganic chemistry · 25 May 2026 PMID 42184581
- Promising Flavonoid-Fused Aminoquinolines as Synthetic Alzheimer's Disease Models: Design, Synthesis, Anticholinesterase Activity, ADMET and Molecular Docking. Chembiochem : a European journal of chemical biology · 25 May 2026 PMID 42179001
- Studies of design, synthesis and biological properties, ADMET profiling, molecular docking, network pharmacology and molecular dynamics simulation of novel chalcone derivatives containing benzoyl-piperazin. Bioorganic chemistry · 21 May 2026 PMID 42166963
Amyloid–Cholinesterase Alzheimer Therapy (7)
- Antiglycation and Amyloid-β Inhibitory Activities of Pandanus odorifer Extracts and Isolated Constituents: In Vitro and Molecular Docking Insights. Chemistry & biodiversity · 31 Aug 2026 PMID 42672905
- Engineering ApoE3-Targeted NIR-Responsive Liposomes for Multimodal Inhibition of Amyloid-β Aggregation and Acetylcholinesterase Activity. ACS chemical neuroscience · 19 Aug 2026 PMID 42615643
- Overcoming acidic limitations: an Os-Ru bimetallic polymeric nanozyme at neutral pH for dual-mode detection of acetylcholinesterase activity and its inhibitors. Journal of materials chemistry. B · 5 Aug 2026 PMID 42555526
- Rationally designed phytochemical-derived carbamate hybrids unveiling potent inhibition of cholinesterase and amyloid-β peptides. Bioorganic chemistry · 11 Jul 2026 PMID 42435703
- Polydatin inhibits hippocampal neurodegeneration in diabetic rats via modulation of oxidative stress and NF-kB/COX-2/IL-6 inflammatory pathway. Metabolic brain disease · 9 Jul 2026 PMID 42423809
- Engineering a nanocluster-immobilized MOF@MOF architecture-based ratiometric fluorescence bioassay for sensing neurodegenerative disease-related acetylcholinesterase and inhibitor drugs. Analytical methods : advancing methods and applications · 7 Jul 2026 PMID 42411317
- Single molecule, dual actions: GSK-3β/AChE dual inhibition for Alzheimer's disease. European journal of medicinal chemistry · 19 Jun 2026 PMID 42320199
Natural Product AChE Discovery (4)
- Affinity-guided and activity-oriented consecutive-CCC/UNIFAC of acetylcholinesterase-binding ginsenosides from Black ginseng: Extraction optimization and activity characterization. Journal of chromatography. A · 22 Sept 2026 PMID 42772259
- Valorization of Ficus carica Pruning Residues as Selective Botanical Insecticides: Optimized Furanocoumarin Extraction, Efficacy Against Neotropical Stink Bugs, and Mechanistic Insights via Molecular Docking. Archives of insect biochemistry and physiology · 1 Aug 2026 PMID 42541399
- Therapeutic potential of Echinocactus grusonii and its associated endophytic fungus Aspergillus oryzae in neuroprotection: in vitro and in silico investigations. Scientific reports · 29 Jul 2026 PMID 42527432
- Metabolomics of Andrographis paniculata Burm. F. green extracts by an integrated LC-MS and NMR approach and evaluation of acetylcholinesterase and tyrosinase inhibitory activity of extracts and isolated compounds. Fitoterapia · 6 Jun 2026 PMID 42250615
Chemical Evaluation of AChE Modulators (3)
- Comprehensive Chemical and Biological Assessment of Orobanche racemosa Extracts Using Chromatographic, In Vitro, In Silico, and Cell-Based Techniques. ChemistryOpen · 18 Aug 2026 PMID 42608938
- High-performance liquid chromatography - diode array detection method validation for amentoflavone-type biflavonoids in five Encephalartos species with potential neuroprotective activity. Scientific reports · 13 Jul 2026 PMID 42443245
- Design, Synthesis, and Biological Evaluation of Chiral Urea and Thiourea Derivatives as Multitarget-Directed Anti-Alzheimer Agents. Drug development research · 6 Jul 2026 PMID 42403010
By study type
Human data, design not indexed (9)
- Molecular Insights on the Reduction-Dependent Electronic Modulation of Graphene Oxide Surface Toward Reactivity and Acetylcholinesterase Inhibition of Alzheimer's Drugs. Chemphyschem : a European journal of chemical physics and physical chemistry · 5 Nov 2026 PMID 42984381
- Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors. Drug development research · 14 Sept 2026 PMID 42734044
- Design, synthesis and multitarget evaluation of cyclopropyl-appended thiohydantoin derivatives as dual cholinesterase and COX inhibitors with antioxidant activity: a combined experimental and computational study. Journal of computer-aided molecular design · 11 Sept 2026 PMID 42726329
- Antiglycation and Amyloid-β Inhibitory Activities of Pandanus odorifer Extracts and Isolated Constituents: In Vitro and Molecular Docking Insights. Chemistry & biodiversity · 31 Aug 2026 PMID 42672905
- Phenylsulfonylethyl-Substituted Benzimidazolium Salts: Synthesis, Characterization, Crystal Structure, Molecular Docking, and Inhibitory Properties Against Various Enzymes. Journal of biochemical and molecular toxicology · 26 Jul 2026 PMID 42502223
- Engineering a nanocluster-immobilized MOF@MOF architecture-based ratiometric fluorescence bioassay for sensing neurodegenerative disease-related acetylcholinesterase and inhibitor drugs. Analytical methods : advancing methods and applications · 7 Jul 2026 PMID 42411317
- Novel 2-indolinone benzylpiperidine- thiosemicarbazone hybrids as cholinesterase inhibitors: Design, synthesis and biological evaluation. Bioorganic chemistry · 29 Jun 2026 PMID 42372459
- β-Maltose-conjugated acetophenone thiosemicarbazones as multitarget inhibitors of diabetes- and Alzheimer's disease-related enzymes: Design, synthesis, and mechanistic evaluation. Bioorganic chemistry · 25 May 2026 PMID 42184581
- Promising Flavonoid-Fused Aminoquinolines as Synthetic Alzheimer's Disease Models: Design, Synthesis, Anticholinesterase Activity, ADMET and Molecular Docking. Chembiochem : a European journal of chemical biology · 25 May 2026 PMID 42179001
Preclinical: animal, cell and lab studies (34)
- Towards Greener Pastures in Alzheimer's Therapy: Synthesis and XRD/HSA/DFT Mechanistic Investigation of Novel Trifluoromethylated Compounds. Archiv der Pharmazie · 29 Oct 2026 PMID 42956264
- Discovery of novel pyridine-2-tetrazole derivatives as in vivo memory enhancement agents. Bioorganic chemistry · 28 Oct 2026 PMID 42950793
- New hybrid molecules with 2,3,4,9-tetrahydro-1H-carbazol-1,3,4-oxadiazole-N-phenylacetamide framework as potent cholinesterase inhibitors. Future medicinal chemistry · 22 Oct 2026 PMID 42904391
- Structural optimization of donepezil-like hybrids toward an improved multi-target and ADME-related profile. Bioorganic chemistry · 2 Oct 2026 PMID 42826663
- Novel pyrimidine-based N-Acylhydrazones as dual AChE inhibitors and antioxidants targeting Alzheimer's disease. Bioorganic chemistry · 28 Sept 2026 PMID 42804920
- Affinity-guided and activity-oriented consecutive-CCC/UNIFAC of acetylcholinesterase-binding ginsenosides from Black ginseng: Extraction optimization and activity characterization. Journal of chromatography. A · 22 Sept 2026 PMID 42772259
- Neuroprotective potential of synthesized coumarin-based glycinate and heterocyclic amide derivatives: an acetylcholinesterase inhibition study. Scientific reports · 25 Aug 2026 PMID 42642505
- Sulfonamide-Based 2-Amino-1,3,4-Oxadiazole Derivatives as Dual Cholinesterase and Carbonic Anhydrase Inhibitors: Design, Synthesis, Kinetic Characterization, Molecular Modeling, and ADMET Evaluation. Drug development research · 25 Aug 2026 PMID 42638586
- Design, Synthesis, and Biological Evaluation of Benzimidazol-2-One Hybrids as Potential Anti-Alzheimer's Disease Agents. Drug development research · 20 Aug 2026 PMID 42623026
- Engineering ApoE3-Targeted NIR-Responsive Liposomes for Multimodal Inhibition of Amyloid-β Aggregation and Acetylcholinesterase Activity. ACS chemical neuroscience · 19 Aug 2026 PMID 42615643
- Comprehensive Chemical and Biological Assessment of Orobanche racemosa Extracts Using Chromatographic, In Vitro, In Silico, and Cell-Based Techniques. ChemistryOpen · 18 Aug 2026 PMID 42608938
- Dual enzymatic inhibition and toxicity profiling of polymethoxylated flavones isolated from Knema malayana. Journal of computer-aided molecular design · 7 Aug 2026 PMID 42563004
- Overcoming acidic limitations: an Os-Ru bimetallic polymeric nanozyme at neutral pH for dual-mode detection of acetylcholinesterase activity and its inhibitors. Journal of materials chemistry. B · 5 Aug 2026 PMID 42555526
- Valorization of Ficus carica Pruning Residues as Selective Botanical Insecticides: Optimized Furanocoumarin Extraction, Efficacy Against Neotropical Stink Bugs, and Mechanistic Insights via Molecular Docking. Archives of insect biochemistry and physiology · 1 Aug 2026 PMID 42541399
- Central cholinergic modulation of the cough reflex: suppressive effects of donepezil in rabbits. American journal of physiology. Lung cellular and molecular physiology · 31 Jul 2026 PMID 42537636
- Therapeutic potential of Echinocactus grusonii and its associated endophytic fungus Aspergillus oryzae in neuroprotection: in vitro and in silico investigations. Scientific reports · 29 Jul 2026 PMID 42527432
- Design, synthesis, biological evaluation, and in silico analysis of novel coumarin carboxamides as acetylcholinesterase and butyrylcholinesterase inhibitors and anticancer agents. Journal of computer-aided molecular design · 21 Jul 2026 PMID 42481895
- Rational design and synthesis of dispiroindene-pyrrolidinedione scaffolds as multi-target directed ligands: potent AChE inhibitors with antioxidant activity and favorable biocompatibility in SH-SY5Y cells. Bioorganic chemistry · 16 Jul 2026 PMID 42462519
- High-performance liquid chromatography - diode array detection method validation for amentoflavone-type biflavonoids in five Encephalartos species with potential neuroprotective activity. Scientific reports · 13 Jul 2026 PMID 42443245
- Eugenol-derived carbamates as sub-nanomolar dual cholinesterase inhibitors with neuroprotective activity against Alzheimer's disease: Structure-activity relationships and molecular dynamics insights. Bioorganic chemistry · 13 Jul 2026 PMID 42442298
- Rationally designed phytochemical-derived carbamate hybrids unveiling potent inhibition of cholinesterase and amyloid-β peptides. Bioorganic chemistry · 11 Jul 2026 PMID 42435703
- Polydatin inhibits hippocampal neurodegeneration in diabetic rats via modulation of oxidative stress and NF-kB/COX-2/IL-6 inflammatory pathway. Metabolic brain disease · 9 Jul 2026 PMID 42423809
- Design, Synthesis, and Biological Evaluation of Chiral Urea and Thiourea Derivatives as Multitarget-Directed Anti-Alzheimer Agents. Drug development research · 6 Jul 2026 PMID 42403010
- RANQSAR: a standalone open-source application for reproducible machine learning-based QSAR analysis. Journal of computer-aided molecular design · 2 Jul 2026 PMID 42390765
- From Poisoning to Signal Transduction: d-Band Modulated Au@RuPt Nanozyme for Oxygen Reduction Reaction Inhibition-Based Detection of Organophosphates. Analytical chemistry · 1 Jul 2026 PMID 42384538
- Single molecule, dual actions: GSK-3β/AChE dual inhibition for Alzheimer's disease. European journal of medicinal chemistry · 19 Jun 2026 PMID 42320199
- Ferric chloride mediated synthesis, photophysical and in vitro anti-Alzheimer's properties of 1H-pyrrolo[2,3-b]pyridin-3-ylmethylphenyl-2-(9H-fluoren-9-ylidene)-1-phenylethan-1-imines. Organic & biomolecular chemistry · 19 Jun 2026 PMID 42318800
- The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer's disease induced by intracerebroventricular injection of streptozotocin. Brain structure & function · 14 Jun 2026 PMID 42289507
- Metabolomics of Andrographis paniculata Burm. F. green extracts by an integrated LC-MS and NMR approach and evaluation of acetylcholinesterase and tyrosinase inhibitory activity of extracts and isolated compounds. Fitoterapia · 6 Jun 2026 PMID 42250615
- Design, synthesis and evaluation of an uncharged broad spectrum quinoline-oxime hybrid for the reactivation of nerve agent-inhibited human acetylcholinesterase. European journal of medicinal chemistry · 4 Jun 2026 PMID 42241775
- Evaluation of the Phytochemical Composition, Antioxidant Activity, and Enzyme Inhibitory Potential of Salvia heldreichiana Within the Framework of Molecular Docking and CAVER Tunnel Analysis. ChemistryOpen · 1 Jun 2026 PMID 42220228
- Identification of a nanomolar, selective MAO-B inhibitor from piperidine-based chalcones with anti-Parkinson potential. Bioorganic chemistry · 26 May 2026 PMID 42190536
- Bismuth hybrid halide with dual inhibition against α-amylase and acetylcholinesterase probed by structural, vibrational, and theoretical analysis. Journal of materials chemistry. B · 22 May 2026 PMID 42171151
- Studies of design, synthesis and biological properties, ADMET profiling, molecular docking, network pharmacology and molecular dynamics simulation of novel chalcone derivatives containing benzoyl-piperazin. Bioorganic chemistry · 21 May 2026 PMID 42166963
Written from 43 PubMed abstracts, each one listed by PMID above. Published: 2026-06-14. Last written: 2026-09-13 by GPT. Reviewed by a human editor on 2026-07-23. Drafted by language models from published abstracts; not medical advice.